Ingalls & Snyder LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 4.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,308 shares of the company’s stock after selling 2,295 shares during the period. Ingalls & Snyder LLC’s holdings in Colgate-Palmolive were worth $3,394,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently added to or reduced their stakes in the company. Julex Capital Management LLC bought a new stake in Colgate-Palmolive in the third quarter worth $27,000. Quest Capital Management Inc. ADV bought a new stake in Colgate-Palmolive in the third quarter worth $31,000. Horan Capital Advisors LLC. bought a new stake in Colgate-Palmolive in the third quarter worth $32,000. KCS Wealth Advisory bought a new stake in Colgate-Palmolive in the third quarter worth $34,000. Finally, Evoke Wealth LLC bought a new stake in Colgate-Palmolive in the third quarter worth $37,000. Hedge funds and other institutional investors own 76.69% of the company’s stock.
Several brokerages recently weighed in on CL. Bank of America cut shares of Colgate-Palmolive from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $77.00 to $74.00 in a research report on Thursday, December 19th. Berenberg Bank initiated coverage on shares of Colgate-Palmolive in a research note on Wednesday, October 16th. They set a “sell” rating and a $58.00 price objective for the company. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $70.00 price objective for the company. in a research note on Monday, November 4th. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $78.00 to $76.00 and set a “neutral” rating for the company in a research note on Monday, October 14th. Finally, Deutsche Bank lifted their price objective on shares of Colgate-Palmolive from $72.00 to $73.00 and gave the stock a “hold” rating in a research note on Thursday, December 12th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $72.85.
In other news, Chairman Ian M. Cook sold 17,750 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $68.30, for a total transaction of $1,212,325.00. Following the completion of the sale, the chairman now directly owns 995,075 shares of the company’s stock, valued at $67,963,622.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Ian M. Cook sold 16,000 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $66.70, for a total transaction of $1,067,200.00. Following the sale, the chairman now directly owns 1,099,361 shares of the company’s stock, valued at $73,327,378.70. The disclosure for this sale can be found here. Insiders have sold 67,500 shares of company stock valued at $4,569,293 over the last three months. Insiders own 1.14% of the company’s stock.
NYSE CL opened at $70.80 on Thursday. The company has a quick ratio of 0.70, a current ratio of 1.03 and a debt-to-equity ratio of 43.94. The company has a fifty day moving average of $68.57 and a two-hundred day moving average of $70.35. The firm has a market capitalization of $60.24 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 5.45 and a beta of 0.71. Colgate-Palmolive has a 52 week low of $60.96 and a 52 week high of $76.41.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, November 1st. The company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.70 by $0.01. The company had revenue of $3.93 billion during the quarter, compared to analyst estimates of $3.95 billion. Colgate-Palmolive had a net margin of 15.04% and a return on equity of 6,492.71%. Colgate-Palmolive’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.72 earnings per share. Equities research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date is Wednesday, January 22nd. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Further Reading: What is a support level?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.